Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
New directory helps connect low-income women to cervical cancer services in North Carolina
A new online resource is available to help connect women and adolescents to life-saving cervical cancer-related services.
Located in News / 2012 News
Informatics approach helps doctors, patients make sense of genome data
Chapel Hill, NC – The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient’s genomic data may be less expensive than undertaking one or two targeted genetic tests.
Located in News / 2012 News
UNC scientists funded to study genome sequencing in clinical settings
Chapel Hill - The complete sequence of an individual’s genome – all 3 billion DNA building blocks - will soon be affordably available to doctors, patients and even consumers. While knowledge of one’s genome may have important medical benefits, tremendous questions remain regarding an avalanche of such data means and how they should be used. Many clinical, ethical and social issues arise from the evaluation, use and sharing of the data.
Located in News / 2011 News
The V Foundation selects UNC team as 2012 translational grant recipients
The V Foundation for Cancer Research, one of the nation’s leading cancer research foundations, has awarded a $600,000 grant to a UNC Lineberger team.
Located in News / 2012 News
Exercise, even mild physical activity, may reduce breast cancer risk
A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity - either mild or intense and before or after menopause - may reduce breast cancer risk, but substantial weight gain may negate these benefits.
Located in News / 2012 News
Genetically-engineered preclinical models predict pharmacodynamic response
Preclinical testing a necessary step in drug development
Located in News / 2012 News
Robert Millikan, cancer researcher, gentle colleague, dies Oct. 7
A brilliant and beloved scientist has left us too early. Dr. Robert Millikan, Barbara Sorenson Hulka Distinguished Professor of Cancer Epidemiology, died Sunday, October 7. He was 55.
Located in News / 2012 News
UNC-Chapel Hill, ECU Team up on Cancer Care, Research
CHAPEL HILL - The University of North Carolina’s two medical schools and their cancer centers have signed a memorandum of understanding that creates a partnership to advance cancer research and bring leading-edge treatment to North Carolinians.
Located in News / 2011 News
Researchers identify components that keep immune system in check
CHAPEL HILL – Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body’s own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.
Located in News / 2011 News
Bae-Jump receives grant to study impact of obesity on ovarian cancer
Victoria Bae-Jump, MD, PhD, has received a two-year $200,000 grant from the Department of Defense, to study “Preclinical and Clinical Investigations of the Impact of Obesity on Ovarian Cancer Pathogenesis.”
Located in News / 2012 News